Thus, selective inhibition of the glycosylation enzymes that are responsible for core fucosylation, e.g., α1,6-fucosyltransferase (FUT8), will likely attenuate increased core fucosylation that was found on these glycoproteins in HCC tumor and serves as a potential therapeutic strategy for HCC. Here, FUT8 is linked to neoplasm.